VERSES Identifies New Path to AGI and Extends Invitation to OpenAI for Collaboration via Open Letter
VERSES Active Inference, Approach to AGI Grounded in Neuroscience and Physics Led by Top Neuroscientist and Chief Science Officer Karl...
Read moreVERSES Active Inference, Approach to AGI Grounded in Neuroscience and Physics Led by Top Neuroscientist and Chief Science Officer Karl...
Read moreSOUTH SAN FRANCISCO, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel...
Read moreInterconnected healthcare sectors like pain management devices and patches are shaping the topical pain relief market. Forecasts indicate fuelled by...
Read moreLow-cost financing capitalizes on XOMA’s $14 million acquisition of VABYSMO® (faricimab) royalties in 2021 Proceeds expected to be used for stock...
Read moreFourth Quarter Fiscal 2023 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenues of $22.5 million compared to $39.2 millionGross...
Read moreC3D enables optimized networking performance and security featuresLOS ANGELES, Dec. 19, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – IBN a...
Read more~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to...
Read moreNetDevOps Days from NetBox Labs to Merge with Network Automation Forum’s AutoCon, Concentrating the Focus of the Network Automation Ecosystem...
Read moreNEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000...
Read moreSUNNYVALE, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the treatment...
Read more